Weill Cornell Medical College and NewYork-Presbyterian Hospital in New York City have announced that they will partner to create an Institute for Precision Medicine at Weill Cornell and NewYork-Presbyterian/Weill Cornell Medical Center, also in New York City.
The institute will explore targeted, individualized medical treatments based on each patient's genetic profile. Preventive precision medicine will also be a key initiative at the institute. It will be led by Mark Rubin, MD, a pathologist and prostate cancer expert at NewYork-Presbyterian/Weill Cornell Medical Center.
What Personalized Medicine Means for Hospitals
University of Michigan Health System Launches Joint Venture for Personalized Medicine
The institute will explore targeted, individualized medical treatments based on each patient's genetic profile. Preventive precision medicine will also be a key initiative at the institute. It will be led by Mark Rubin, MD, a pathologist and prostate cancer expert at NewYork-Presbyterian/Weill Cornell Medical Center.
More Articles on Personalized Medicine:
4 Best Practices for Setting up a Molecular Medicine InstituteWhat Personalized Medicine Means for Hospitals
University of Michigan Health System Launches Joint Venture for Personalized Medicine